Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale and more continuous clinical data inside hospitals. The post Danaher Drops $10B to Snatch…
Novartis’s alliance with Unnatural Products is pursuing next-generation peptide drugs for cardiovascular disease. The startup already has drug R&D alliances with BridgeBio Pharma, Merck, and Argenx. The post Novartis Commits $100M to Startup With Tech That Brings Peptides to Undruggable Targets appeared first on MedCity News.
Instead of adding more layers of complexity to an already strained system, there’s a more effective solution: make it simpler for independent clinicians to run a practice, participate in insurance networks directly, coordinate care, and provide treatment. The post Sustaining Clinician Independence: Why Simplicity, Not Consolidation, Is Key to Solving the Mental Health Crisis appeared…
Imaging has become a core input into how health systems understand disease, evaluate outcomes, plan capacity, and increasingly, how they learn. The post Imaging Data Liquidity: The Foundation of Multimodal Medical Intelligence appeared first on MedCity News.
The head of Anthropic’s biology and life sciences business spoke about introducing “first-party” products, having a presence inside the EHR and what Claude can do for rural hospitals. The post Anthropic: It’s “Critical” To Bring Company Products to EHR appeared first on MedCity News.
Solera Health has launched a behavioral health network that connects members to partners Calm Health and Lyra Health for digital mental health, coaching and therapy services. The post Solera Health Launches Behavioral Health Network with Calm and Lyra appeared first on MedCity News.
CSL Limited retain rights to clazakizumab in end-stage kidney disease. Eli Lilly gets rights to the the IL-6-blocking antibody in other indications that could put it in competition with Novo Nordisk and Novartis. The post Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug appeared first on MedCity News.
Healthcare leaders must resist using AI as a substitute for staffing. Instead, invest in workforce optimization technology that empowers nurses, creates flexible pathways, and addresses the systemic issues driving burnout. The post Healthcare’s AI Obsession Is Missing the Point on Nursing Shortages appeared first on MedCity News.
Here are some of the structural and strategic causes behind that failure rate, and ways to improve launch outcomes. The post Addressing the 58% Launch Failure Rate: Accelerating Market Access Through Intelligent Decision-Making appeared first on MedCity News.
Daffodil’s Series A round was led by Flare Capital Partners, with participation from LRVHealth and Maverick Ventures. The post Daffodil Health Secures $16.3M for Health Plan Administration Platform appeared first on MedCity News.